Selected Publications
Jessica M. Stempel, Geoffrey L. Uy, Shira N. Dinner, Ivana Gojo, Daniel R Reed, Rupali Roy, Kenneth P Byrd, Swaroopa Yerrabothala, Catherine E. Lai, Kimberley Doucette, Anne Caldwell, Ondrej Blaha, Nikolai A. Podoltsev, Lourdes M Mendez, Jan Philipp Bewersdorf, Tariq Kewan, Ignacio Wistuba, Gheath Alatrash, Cara L Haymaker, Howard Streicher, Elad Sharon, Richard F. Little, Steven D. Gore, Jerald P. Radich, Brent L. Wood, Amer M. Zeidan, Rory M. Shallis: Efficacy and Safety of Pembrolizumab Added to Azacitidine Plus Venetoclax for Patients with Acute Myeloid Leukemia: Results from an Investigator-Initiated, Multi-Center, CTEP-Sponsored Randomized, Phase II Trial (BLAST AML-2) Blood : 2024.
Catherine E. Lai, Thomas P. Leahy, Alex Turner, Amber Thomassen, Lixia Wang, Aaron Sheppard, Jorge E. Cortes: Effectiveness of Olutasidenib Versus Ivosidenib in Patients with Mutated Isocitrate Dehydrogenase 1 Acute Myeloid Leukemia Who Are Relapsed or Refractory to Venetoclax: The 2102-HEM-101 Trial Versus a US Electronic Health Record-Based External Control Arm Blood : 2024.
Mark Roschewski, Christopher Melani, Rahul Lakhotia, Tatyana Gavrilova, Jagan R. Muppidi, James D. Phelan, Michail S. Lionakis, Kieron Dunleavy, Lode J. Swinnen, Matthias Holdhoff, Catherine E. Lai, Sami Ibrahimi, Michael Glantz, Jan Drappatz, John A. Butman, Stefania Pittaluga, Kim Johnson, Candis Morrison, Nick Micheletti, John D. Heiss, William D. Figg, Elaine S. Jaffe, S. Percy Ivy, Richard F. Little, Louis M. Staudt, Wyndham H. Wilson: Phase 1 Study of Escalating Doses of Ibrutinib in Teddi-R with Isavuconazole for Relapsed and Refractory Primary DLBCL of the CNS Blood : 2024.
Jayakumar Vadakekolathu, Sarah Skuli, David J Boocock, Clare Coveney, Eruchi G Ikpo, Bofei Wang, Elena M Fenu, Hussein A. Abbas, MD, Catherine E. Lai, Martin P Carroll, Sergio Rutella: Multi-Omic Analyses of TP53-Mutated Acute Myeloid Leukemia Identify Prognostic Metabolic Signatures Blood : 2024.
Rowe, Margaret; Babushok, Daria V.; Carroll, Martin; Carulli, Alison; Frey, Noelle V.; Gill, Saar; Hexner, Elizabeth; Hirsh, Rebecca; Hossain, Nasheed; Lai, Catherine; Loren, Alison; Luger, Selina; Maillard, Ivan; McCurdy, Shannon R.; Matthews, Andrew; Martin, Mary Ellen; R, Vikram Paralkar; Perl, Alexander E.; Porter, David; Pratz, Keith W.; Stadtmauer, Edward; Bruno, Ximena Jordan: Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated with a Venetoclax Based Regimen: A Real World Single Center Experience European Journal of Haematology : 2024.
Chauhan A, Lai C, Kuhr F, Simmons H, Cheson BD: Long-Term Follow-Up of Patients With Follicular Lymphoma Using Next Generation Sequencing to Detect Minimal Residual Disease Clin Lymphoma Myeloma Leuk : 2024.
Dykes KC, Chou J, Taylor AO, Shu AC, Mudra SE, Ma X, Ahn J, Lai CE: Survival outcomes in older adult acute lymphoblastic leukemia (ALL) patients analyzed by facility volume and type: a National Cancer Database (NCDB) analysis Cancer Rep : 2024.
Xie Z, Komrokji RS, Al-Ali N, Regelson A, Geyer S, Patel AA, Saygin C, Zeidan AM, Bewersdorf JP, Mendez LM, Kishtagari A, Zeidner JF, Coombs CC, Madanat YF, Chung SS, Badar T, Foran JM, Desai P, Tsai C, Griffiths EA, Al Malki MM, Amanam I, Lai C, Deeg HJ, Ades L, Arana-Yi C, Osman AE, Dinner SN, Abaza Y, Taylor J, Chandhok NS, Soong D, Brunner AM, Carraway HE, Singh A, Elena C, Ferrari J, Galli A, Pozzi S, Padron E, Patnaik MM, Malcovati L, Savona MR, Al-Kali A.: Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence Blood : 2024.
Williams LS, Nagaradona T, Nalamalapu P, Lai C.: Breaking down frailty: Assessing vulnerability in acute myeloid leukemia Blood Rev : 2024.
Connor MP, Prathapa N, Frey NV, Gill SI, Hexner EO, Bruno XJ, Lai CE, Loren AW, Luger SM, Matthews AH, McCurdy SR, Perl AE, Porter DL, Zeringue A, Oved JH, Olson TS, Pratz KW, Babushok DV: Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia Haematologica : 2024.
Academic Contact Information
Abramson Cancer Center
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
12 South Pavillion
Philadelphia,
PA
19104
Phone: 215-349-8940
Patient appointments: 800-789-7366